<DOC>
	<DOCNO>NCT02002052</DOCNO>
	<brief_summary>Concurrent chemoradiotherapy standard treatment locally advance , unresectable non-small cell lung cancer , carry risk radiation pneumonitis approximately 30 % , associate decline pulmonary quality life . Standard radiation planning aim optimize dose anatomic lung volume , without consideration difference regional lung function . Functional lung avoidance radiotherapy aim reduce radiotherapy dose region function lung , instead deposit dose area lung well-ventilated . Functional lung region determine use noble-gas MRI co-registered radiotherapy planning CT scan . Functional lung avoidance radiotherapy demonstrate feasible , trial aim compare outcomes standard radiotherapy ( concurrent chemotherapy ) vs. functional lung avoidance radiotherapy ( concurrent chemotherapy ) .</brief_summary>
	<brief_title>Functional Lung Avoidance Individualized Radiotherapy ( FLAIR ) : A Randomized , Double-Blind Clinical Trial</brief_title>
	<detailed_description>All consent patient undergo hyperpolarized noble gas MRI use 3-He definition functional lung volume . Two radiotherapy treatment plan generate prior randomization : one standard plan use anatomical lung avoidance , one functional lung avoidance plan . After approval plan , patient randomize , patient physician blind treatment allocation .</detailed_description>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Age 18 old Willing provide inform consent ECOG performance status 02 Histologically confirm nonsmall cell lung carcinoma Locally advance Stage IIIA IIIB lung carcinoma accord AJCC 7th edition History least 10packyears smoke Not undergo surgical resection Assessment medical oncologist radiation oncologist , adequate bone marrow , hepatic renal function administration platinumbased chemotherapy Contraindications MRI Serious medical comorbidities ( unstable angina , sepsis ) contraindication radiotherapy chemotherapy Prior history lung cancer within 5 year Prior thoracic radiation time Metastatic disease . Patients present oligometastatic disease metastasis ablate ( surgery radiotherapy ) candidate receive chemoradiotherapy thoracic disease curative intent . Inability attend full course radiotherapy followup visit Pregnant lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>non-small cell lung cancer , radiotherapy , chemotherapy , pneumonitis , functional lung avoidance</keyword>
</DOC>